Assetmark, Inc Novavax Inc Put Options Transaction History
Assetmark, Inc
- $45.6 Billion
- Q3 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding NVAX
# of Institutions
307Shares Held
94.9MCall Options Held
6.11MPut Options Held
10.7M-
Vanguard Group Inc Valley Forge, PA15.2MShares$115 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$89.9 Million0.0% of portfolio
-
Shah Capital Management11.5MShares$87.4 Million35.13% of portfolio
-
State Street Corp Boston, MA6.82MShares$51.8 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.94MShares$29.9 Million0.02% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $594M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...